Literature DB >> 10746785

Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease.

A Fogdell-Hahn1, A Ligers, M Grønning, J Hillert, O Olerup.   

Abstract

Multiple sclerosis (MS) is a presumed autoimmune disease of the central nervous system, shown to be associated with the HLA class II haplotype DRB1*15,DQB1*06. Carrying the HLA class II haplotype DRB1*15,DQB1*06 increases the risk of MS by 3.6. By adopting a polymerase chain reaction (PCR)-based typing technique for HLA class I and class II genes, 200 Swedish MS patients and 210 Swedish healthy controls were analysed for their HLA alleles. Additional HLA class I alleles that increase and decrease the genetic susceptibility to MS were identified. The HLA-A*0301 allele increases the risk of MS (odds ratio=2.1) independently of DRB1*15,DQB1*06. HLA-A*0201 decreases the overall risk (odds ratio= 0.52) and the presence of A*0201 reduces the risk of MS for DRB1*15,DQB1*06 carriers from 3.6 to 1.5. Our findings are the first to identify a major modulating effect of HLA class I alleles on the susceptibility to a human autoimmune disease; a phenomenon that has previously only been observed in animal models.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10746785     DOI: 10.1034/j.1399-0039.2000.550205.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  78 in total

1.  Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis.

Authors:  Justin P Rubio; Melanie Bahlo; Niall Tubridy; Jim Stankovich; Rachel Burfoot; Helmut Butzkueven; Caron Chapman; Laura Johnson; Mark Marriott; Grant Mraz; Brian Tait; Chris Wilkinson; Bruce Taylor; Terence P Speed; Simon J Foote; Trevor J Kilpatrick
Journal:  Hum Genet       Date:  2004-03-11       Impact factor: 4.132

Review 2.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

Review 3.  The genetics of multiple sclerosis: an up-to-date review.

Authors:  Pierre-Antoine Gourraud; Hanne F Harbo; Stephen L Hauser; Sergio E Baranzini
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

4.  A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome.

Authors:  Alessandro Didonna; Noriko Isobe; Stacy J Caillier; Kathy H Li; Alma L Burlingame; Stephen L Hauser; Sergio E Baranzini; Nikolaos A Patsopoulos; Jorge R Oksenberg
Journal:  Hum Mol Genet       Date:  2015-10-03       Impact factor: 6.150

5.  Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype.

Authors:  Mireia Sospedra; Paolo A Muraro; Irena Stefanová; Yingdong Zhao; Katherine Chung; Yili Li; Marc Giulianotti; Richard Simon; Roy Mariuzza; Clemencia Pinilla; Roland Martin
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

6.  Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.

Authors:  Justin P Rubio; Melanie Bahlo; Jim Stankovich; Rachel K Burfoot; Laura J Johnson; Stewart Huxtable; Helmut Butzkueven; Ling Lin; Bruce V Taylor; Terence P Speed; Trevor J Kilpatrick; Emmanuel Mignot; Simon J Foote
Journal:  Immunogenetics       Date:  2007-01-26       Impact factor: 2.846

Review 7.  From genes to function: the next challenge to understanding multiple sclerosis.

Authors:  Lars Fugger; Manuel A Friese; John I Bell
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

8.  Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.

Authors:  Nicolas Fissolo; Sabrina Haag; Katrien L de Graaf; Oliver Drews; Stefan Stevanovic; Hans Georg Rammensee; Robert Weissert
Journal:  Mol Cell Proteomics       Date:  2009-06-16       Impact factor: 5.911

9.  Variability in the CIITA gene interacts with HLA in multiple sclerosis.

Authors:  A Gyllenberg; F Piehl; L Alfredsson; J Hillert; I L Bomfim; L Padyukov; M Orho-Melander; E Lindholm; M Landin-Olsson; Å Lernmark; T Olsson; I Kockum
Journal:  Genes Immun       Date:  2014-01-16       Impact factor: 2.676

10.  Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.

Authors:  Katarina Tengvall; Jesse Huang; Cecilia Hellström; Patrick Kammer; Martin Biström; Burcu Ayoglu; Izaura Lima Bomfim; Pernilla Stridh; Julia Butt; Nicole Brenner; Angelika Michel; Karin Lundberg; Leonid Padyukov; Ingrid E Lundberg; Elisabet Svenungsson; Ingemar Ernberg; Sigurgeir Olafsson; Alexander T Dilthey; Jan Hillert; Lars Alfredsson; Peter Sundström; Peter Nilsson; Tim Waterboer; Tomas Olsson; Ingrid Kockum
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.